Colleen Irwin
Psychiatric/Mental Health · Orlando, FLNPI 1922189190
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 25.0% of the total. 2025 is the largest year on record at $2,666, 5.2 times the $508 reported in 2022. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $46.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Axsome Therapeutics, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$962
- Otsuka America Pharmaceutical, Inc.$764
- Johnson & Johnson$757
- Teva Pharmaceuticals USA, Inc.$336
- plus $803 from 10 others
What the payments were for
- Food & beverage$6,209100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 46 | $1,556 |
| Axsome Therapeutics, Inc. | 24 | $1,048 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $962 |
| Otsuka America Pharmaceutical, Inc. | 12 | $764 |
| Johnson & Johnson | 9 | $757 |
| Teva Pharmaceuticals USA, Inc. | 4 | $336 |
| E.r. Squibb & Sons, L.L.C. | 2 | $218 |
| Noven Therapeutics, LLC | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $118 |
| Vanda Pharmaceuticals Inc. | 1 | $118 |
| Lundbeck LLC | 4 | $83 |
| Corium, LLC | 3 | $68 |
| Neurocrine Biosciences, Inc. | 1 | $27 |
| Neos Therapeutics, LP | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$951
- Auvelity$831
- SPRAVATO$646
- CAPLYTA$620
- ABILIFY MAINTENA$355
- REXULTI$241
- ABILIFY ASIMTUFII$233
- Austedo XR$228
- COBENFY$125
- Xelstrym$122
- Fanapt$118
How this compares
$6,228 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 12 | $1,475 |
| Bupropion XlBupropion Hcl | 11 | $213 |
| Duloxetine Hcl | 12 | $196 |
| Risperidone | 11 | $151 |
| Bupropion Hcl SrBupropion Hcl | 11 | $133 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Orlando
- Elizabeth GueldeOrlando$48K
- Amber SiegelOrlando$17K
- Orville MurrayOrlando$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.